Acne Treatment Market to $13.76 billion by 2030

As per the report published by The Brainy Insights, the acne treatment is expected to grow from USD 9.39 billion in 2022 to USD 13.76 billion by 2030, at a CAGR of 4.90% during the forecast period 2022-2030. North America region emerged as the largest market for acne treatment with a 35.9% share of the market revenue in 2022. North America currently dominates the acne treatment market as according to the American Academy of Dermatology (AAD), acne is the most common skin disease in the United States. and impacts up to 55 million Americans yearly. High-stress levels and Unhealthy eating patterns are important causes of acne, which has led to the increasing need for different topical treatments and the growth of new FDA-approved drugs to treat hormonally related acne. For Instance, On 16 September 2020, Food and Drug Administration approved Winlevi, a topical androgen receptor inhibitor that impedes hormones from creating a higher amount of sebum. The existence of essential companies developing anti-acne products and acne therapies and the presence of a considerable number of skincare clinics and skin specialists in countries of the region is anticipated to propel revenue growth of the market in the region.

Get an Inside Scoop of Study, Request now for Sample Study @ https://www.thebrainyinsights.com/enquiry/sample-request/13265

Acne Treatment Market Size by Product Type (Antibiotics, Isotretinoin, Retinoids, and Others), Route of Administration (Topical, Injectable, and Oral), End User (Hospitals, Specialty Centers, and Skincare Clinics), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2022 to 2030

Leading companies in the industry include Almirall S.A., Bausch Health Companies Inc., Bayer AG, Cutera Inc., Galderma Laboratories, GlaxoSmithKline plc., Hoffman La Roche Ltd, Johnson & Johnson Services Inc, Lumenis Ltd, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceutical International, Inc., Vyne Therapeutics Inc., among others which are offering greater opportunities and are continuously focused on new product developments and venture capital investments to obtain market share.

Check Index of Research Study @ https://www.thebrainyinsights.com/report/acne-treatment-market-13265

The product type segment is divided into antibiotics, isotretinoin, retinoids, and others. The retinoid segment dominated the market, with a market share of around 26% in 2022. The route of administration segment is divided into topical, injectable, and oral. The topical segment dominated the market, with a market share of around 36% in 2022. The end user segment is divided into hospitals, specialty centers, and skincare clinics. The hospitals segment dominated the market, with a market share of around 36% in 2022.

The Coronavirus pandemic hampers the production of medicines for acne treatment due to fewer patients looking for the treatment worldwide. Prominent companies in the market reported heavy losses in income due to COVID-19. Further, the rise in healthcare expenses, discontinued supply chains, reduced production, and additional factors impacted the sales of medicines, particularly in the year 2020. For example, research performed with dermatologists in the United States by the American Association of Dermatology noted a nearly 45% drop in weekly patient consultations during the lockdown course corresponding to the pre-coronavirus period.

Enquire for customization in Report @ https://www.thebrainyinsights.com/enquiry/request-customization/13265

About The Brainy Insights:
The Brainy Insights is a market research company, aimed at providing actionable insights through data analytics to companies to improve their business acumen. We have a robust forecasting and estimation model to meet the clients' objectives of high-quality output within a short span of time. We provide both customized (clients' specific) and syndicate reports. Our repository of syndicate reports is diverse across all the categories and sub-categories across domains. Our customized solutions are tailored to meet the clients' requirements whether they are looking to expand or planning to launch a new product in the global market.

Contact Us
Avinash D
Head of Business Development
Phone: +1-315-215-1633
Email: sales@thebrainyinsights.com
Web: www.thebrainyinsights.com

This release was published on openPR.